4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-014475
Exec. VP Chief Legal Officer sold 6,452 shares at $8.14 ($52,533)
- Exec. VP Chief Legal Officer acquired 18,430 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Stark David Matthew · Exec. VP Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 1 in the form | +18,430 | 27,832.39 | D | ||
| 2022-02-28 | Sale : show line 2 in the form | −6,452 | $8.14 | $52,533 | 21,380.39 | D |
| Open-market sales · 6,452 sh · avg $8.14 · $52,533 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 3 in the form Restricted Share Units | −18,430 | 36,860 | D |
Loading xslF345X03/doc4.xml…